Alliance for Vision Research Joins Nearly 400 Organizations Urging Congress to Finalize FY 2027 NIH Funding

Alliance for Vision Research has joined 393 other organizations in urging congressional leaders to move quickly to finalize robust FY 2027 funding for the National Institutes of Health (NIH).

The October 22 letter, organized by the Ad Hoc Group for Medical Research, represents patients, scientists, health professionals, academic and research institutions, educators, industry, and other organizations across the medical research community. Alliance for Vision Research is among the 394 signatories.

The letter emphasizes that timely and predictable federal funding is essential to scientific progress. Delays in appropriations can disrupt NIH grant awards, postpone research and clinical studies, create uncertainty for early-career investigators and research institutions, and ultimately delay the development of new diagnostics, treatments, and preventive strategies.

The coalition also calls for safeguards against federal policies that could further disrupt appropriated research funding, including proposed changes affecting grant termination, political review, and the Uniform Guidance governing federal financial assistance.

For Alliance for Vision Research, the message is clear: research cannot move forward without stability and sustained federal investment. Vision researchers need the certainty to pursue long-term scientific questions, train the next generation of investigators, and move discoveries toward innovations that can prevent vision loss and improve patients’ lives.

The letter urges Congress to complete a strong, bipartisan FY 2027 NIH appropriation as quickly as possible, warning that delays in research funding ultimately mean delays in scientific progress for patients and families.

Alliance for Vision Research will continue advocating for strong, predictable federal investment in NIH and the National Eye Institute and for policies that allow researchers to pursue the science that protects, preserves, and restores sight.